December 23, 2021, 06.09 PM


KOMPAS.com - US drug regulators approved Pfizer’s pill for treating Covid-19 on Wednesday, Dec. 22.

A pill to treat the deadly coronavirus marks a breakthrough as the pandemic enters its third year.

The US Food and Drug Administration's (FDA) authorization paves the way for another significant tool in the fight against the omicron variant. The EU had already previously approved the pill.

US President Joe Biden said the pill was a “significant step forward” on the path towards ending the pandemic, and his administration would work towards ensuring equitable distribution. He also said a law would be invoked to ensure Pfizer could ramp up production.

Also read: Pfizer Deal Authorizes Generic Pharmaceuticals to Produce Covid-19 Antiviral Pill

Pfizer’s clinical trial showed the antiviral pill was 90 percent effective in preventing extreme sickness requiring hospitalization and potential death in patients where there is a grave risk of severe illness.

Recent lab results suggest it is effective against the fast-spreading omicron variant.

What did the US regulator say?

The US authorized the Pfizer pill for treating mild-to-moderate Covid-19 in adults and children 12 years of age and older who weigh a minimum of 40 kilos (88 pounds) and are at high risk of developing severe symptoms of the disease.

In a statement, Patrizia Cavazzoni, the director of the FDA’s Center for Drug Evaluation and Research, said, “This authorization provides a new tool to combat Covid-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe Covid-19.”

Also readIndonesian Health Minister to Offer Sinovac and Pfizer Vaccines for Child Jab 

The drug will be administered by prescription only and should be taken within the first five days of a Covid-19 diagnosis. It is recommended to take the pills every 12 hours over the course of five days beginning as soon as possible with the onset of symptoms.

What has Pfizer said?

Pfizer is prepared to begin immediate deliveries in the US. The company raised its production projections from 80 million pills to 120 million in 2022.

The US government has a contract for 10 million courses of treatment at $530 per treatment course.

The company plans to file a fresh patent next year in a bid to earn full regulatory approval from the FDA.

Sources: AFP, AP, Reuters

Dapatkan update berita pilihan dan breaking news setiap hari dari Kompas.com. Mari bergabung di Grup Telegram "Kompas.com News Update", caranya klik link https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.



Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
May 20, 2022, 07.35 PM

Jakarta Car-Free Day to Resume Sunday

Views
May 20, 2022, 02.42 PM

What to Expect From Biden's Trip to Asia

News
May 12, 2022, 07.22 PM

President Joko Widodo Arrives in the US

Close Ads